Mary Mosher

Array ( [id] => 6431402 [patent_doc_number] => 20100143395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'MATERIAL WITH IMMUNOGENICITY' [patent_app_type] => utility [patent_app_number] => 12/665168 [patent_app_country] => US [patent_app_date] => 2008-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10034 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143395.pdf [firstpage_image] =>[orig_patent_app_number] => 12665168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5415792 [patent_doc_number] => 20090041679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'HUMAN NEUTRALIZING MONOCLONAL ANTIBODIES TO H5N1 INFLUENZA A VIRUS' [patent_app_type] => utility [patent_app_number] => 12/140151 [patent_app_country] => US [patent_app_date] => 2008-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10421 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041679.pdf [firstpage_image] =>[orig_patent_app_number] => 12140151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519688 [patent_doc_number] => 20100203083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'MUTATED STRUCTURAL PROTEIN OF A PARVOVIRUS' [patent_app_type] => utility [patent_app_number] => 12/601651 [patent_app_country] => US [patent_app_date] => 2008-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 32493 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203083.pdf [firstpage_image] =>[orig_patent_app_number] => 12601651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262987 [patent_doc_number] => 20100297177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'MUTATED PARVOVIRUS STRUCTURAL PROTEINS AS VACCINES' [patent_app_type] => utility [patent_app_number] => 12/601639 [patent_app_country] => US [patent_app_date] => 2008-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 53158 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297177.pdf [firstpage_image] =>[orig_patent_app_number] => 12601639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422950 [patent_doc_number] => 20090149405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Virus-like particle containing a Dengue virus recombinant replicon' [patent_app_type] => utility [patent_app_number] => 12/129908 [patent_app_country] => US [patent_app_date] => 2008-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8273 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149405.pdf [firstpage_image] =>[orig_patent_app_number] => 12129908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5348842 [patent_doc_number] => 20090004203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'METHODS OF TREATING MEASLES INFECTIOUS DISEASE IN MAMMALS' [patent_app_type] => utility [patent_app_number] => 12/129606 [patent_app_country] => US [patent_app_date] => 2008-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 32585 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004203.pdf [firstpage_image] =>[orig_patent_app_number] => 12129606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626007 [patent_doc_number] => 08795681 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Raccoon poxvirus expressing rabies glycoproteins' [patent_app_type] => utility [patent_app_number] => 12/128296 [patent_app_country] => US [patent_app_date] => 2008-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 26 [patent_no_of_words] => 29165 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12128296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5360475 [patent_doc_number] => 20090035269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'PARAPOXVIRUSES IN COMBINATION WITH CLASSICAL CYTOTOXIC CHEMOTHERAPEUTIC AGENTS AS BIOCHEMOTHERAPY FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/123360 [patent_app_country] => US [patent_app_date] => 2008-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2068 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20090035269.pdf [firstpage_image] =>[orig_patent_app_number] => 12123360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5348778 [patent_doc_number] => 20090004139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'INTERFERON-BETA AND/OR LAMBDA FOR USE IN TREATING RHINOVIRUS INFECTION IN THE ELDERLY' [patent_app_type] => utility [patent_app_number] => 12/122510 [patent_app_country] => US [patent_app_date] => 2008-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5430 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004139.pdf [firstpage_image] =>[orig_patent_app_number] => 12122510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585022 [patent_doc_number] => 20090104224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'MODIFIED VACCINIA VIRUS ANKARA FOR THE VACCINATION OF NEONATES' [patent_app_type] => utility [patent_app_number] => 12/118841 [patent_app_country] => US [patent_app_date] => 2008-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13363 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104224.pdf [firstpage_image] =>[orig_patent_app_number] => 12118841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343694 [patent_doc_number] => 20100330120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'HUMAN PARAINFLUENZA VIRUSES HAVING SEPARATED P AND C GENES' [patent_app_type] => utility [patent_app_number] => 12/599095 [patent_app_country] => US [patent_app_date] => 2008-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 25053 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330120.pdf [firstpage_image] =>[orig_patent_app_number] => 12599095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6574120 [patent_doc_number] => 20100129326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'PURIFICATION OF VACCINIA VIRUS- AND RECOMBINANT VACCINIA VIRUS-BASED VACCINES' [patent_app_type] => utility [patent_app_number] => 12/598362 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12407 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129326.pdf [firstpage_image] =>[orig_patent_app_number] => 12598362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13100 [patent_doc_number] => 07807346 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'High-throughput assay for virus entry and drug screening' [patent_app_type] => utility [patent_app_number] => 12/151234 [patent_app_country] => US [patent_app_date] => 2008-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 27 [patent_no_of_words] => 13296 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807346.pdf [firstpage_image] =>[orig_patent_app_number] => 12151234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245226 [patent_doc_number] => 20100135902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'PAPILLOMAVIRUS PSEUDOVIRUSES FOR DETECTION AND THERAPY OF TUMORS' [patent_app_type] => utility [patent_app_number] => 12/598684 [patent_app_country] => US [patent_app_date] => 2008-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15728 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20100135902.pdf [firstpage_image] =>[orig_patent_app_number] => 12598684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6575341 [patent_doc_number] => 20100129404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'IMMEDIATE PROTECTION AGAINST PATHOGENS VIA MVA' [patent_app_type] => utility [patent_app_number] => 12/596204 [patent_app_country] => US [patent_app_date] => 2008-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16630 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129404.pdf [firstpage_image] =>[orig_patent_app_number] => 12596204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4778304 [patent_doc_number] => 20080286302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Safe Mutant Viral Vaccines' [patent_app_type] => utility [patent_app_number] => 12/098015 [patent_app_country] => US [patent_app_date] => 2008-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8022 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286302.pdf [firstpage_image] =>[orig_patent_app_number] => 12098015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220037 [patent_doc_number] => 20100055132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'NON-SPECIFIC DELAYED-TYPE HYPERSENSITIVITY RESPONSE TO TREAT HERPES SIMPLEX VIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 12/450586 [patent_app_country] => US [patent_app_date] => 2008-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5674 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055132.pdf [firstpage_image] =>[orig_patent_app_number] => 12450586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8397925 [patent_doc_number] => 08268307 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Enhancing efficacy of vaccines administered via the respiratory tract' [patent_app_type] => utility [patent_app_number] => 12/525735 [patent_app_country] => US [patent_app_date] => 2008-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1711 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12525735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6480047 [patent_doc_number] => 20100092515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'HERPES SIMPLEX VIRUSES AND METHODS OF VIRAL REPLICATION' [patent_app_type] => utility [patent_app_number] => 12/527380 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16757 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092515.pdf [firstpage_image] =>[orig_patent_app_number] => 12527380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4618773 [patent_doc_number] => 07998487 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Antitoxin and vaccine platform based on nodavirus VLPs' [patent_app_type] => utility [patent_app_number] => 12/070384 [patent_app_country] => US [patent_app_date] => 2008-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 26770 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998487.pdf [firstpage_image] =>[orig_patent_app_number] => 12070384 [rel_patent_id] =>[rel_patent_doc_number] =>)